Home/Filings/4/0001562180-24-006090
4//SEC Filing

Greene Barry E 4

Accession 0001562180-24-006090

CIK 0001597553other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:05 PM ET

Size

8.4 KB

Accession

0001562180-24-006090

Insider Transaction Report

Form 4
Period: 2024-08-05
Greene Barry E
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2024-08-05$8.96/sh12,273$109,96685,067 total
  • Award

    Common Stock

    2024-08-05+50,40097,340 total
Footnotes (1)
  • [F1]On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 126,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 50,400 shares.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:05 PM ET
Size
8.4 KB